Back
ESC Premium Access

Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry

Session: Poster Session 3 - Atrial fibrillation - Epidemiology prognosis outcome
Topic: Heart Failure in Atrial Fibrillation
Speaker: Professor S. Dubner (Buenos Aires, AR)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Sergio Jose Dubner

Buenos Aires (Argentina)
0 follower

9 more presentations in this session

Clinical significance of postoperative atrial arrhythmias in patients who underwent lung transplantation

Speaker: Doctor B. Kim (Seoul, KR)

Access
Abstract
Slides
Thumbnail

The CHA2DS2VASc score as a predictor of cardiovascular events in patients without atrial fibrillation

Speaker: Assistant Professor F. Ricci (Chieti, IT)

Access
Abstract
Slides
Thumbnail

Baseline stroke and bleeding risks in the global edoxaban treatment in routine clinical practice in patients with non-valvular atrial fibrillation programme (global ETNA-AF): first snapshot analysis

Speaker: Professor P. Kirchhof (Hamburg, DE)

Access
Abstract
Thumbnail

Paroxysmal atrial fibrillation is very common in a geriatric population evaluated for syncope

Speaker: Doctor R. Jansen (Alkmaar, NL)

Access
Abstract
Thumbnail

The economic burden attributable to atrial fibrillation in nine European countries: perspectives from the GARFIELD-AF registry

Speaker: Mr P. Cozzolino (Monza, IT)

Access
Abstract
Thumbnail

Access the full session

Poster Session 3 - Atrial fibrillation - Epidemiology prognosis outcome

Speakers: Professor S. Dubner, Doctor B. Kim, Assistant Professor F. Ricci, Professor P. Kirchhof, Doctor R. Jansen...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb